Traditional Versus Goal Directed Perioperative Fluid Therapy in High Risk Patients
Postoperative Complications
About this trial
This is an interventional treatment trial for Postoperative Complications focused on measuring Goal directed fluid therapy, perioperative fluid therapy, LiDCOrapid, Postoperative outcome, Open abdominal surgery
Eligibility Criteria
Inclusion Criteria:
- Adult ASA class III & IV (high risk) patients
- >18 years
- scheduled for gastrointestinal surgery involving laparotomy
- Both elective and emergency cases
Exclusion Criteria:
- Atrial fibrillation
- Mental impairment, unable to give informed consent
- Severe aortic or mitral stenosis
- Type of surgery: Liver surgery, transthoracic oesophagectomy
Sites / Locations
- Oulu University Hospital, Department of Anesthesia and Intensive Care
- Haukeland University Hospital
- Stavanger Universityhospital, Division for medical service, anesthesia and intensive care
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Goal directed fluid therapy
Standard monitoring. Initial optimization of fluid status is performed by pulse, BP and anaesthesiologist assessment with Ringer acetate. Followed by an infusion of 10ml/kg/t Ringer acetate. Urinary output and blood pressure is used as a surrogate parameter: the infusion rate is increased by a fall in blood pressure or urine output <0.5ml/kg/t. Bleeding replaced with HES 1:1, otherwise see table for fluid therapy page 9. Vasoactive agents (noradrenaline / phenylephrine) is given if the anesthesiologist considers this necessary. Postoperative give 1000ml Glucose 5%. HES or Ringer when low blood pressure, eventually noradrenaline as vasoactive agent.